Review  

The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded

Melvin R Hayden, James R Sowers, Suresh C Tyagi Cardiovascular Diabetology 2005, 4:9 (28 June 2005)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Review  

Vascular ossification – calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis – calcific uremic arteriolopathy: the emerging role of sodium thiosulfate

Melvin R Hayden, Suresh C Tyagi, Lisa Kolb, James R Sowers, Ramesh Khanna Cardiovascular Diabetology 2005, 4:4 (18 March 2005)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Case Report  

Isolated low high density lipoprotein-cholesterol (HDL-C): implications of global risk reduction. Case report and systematic scientific review

Melvin R Hayden, Suresh C Tyagi Cardiovascular Diabetology 2005, 4:1 (4 January 2005)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central | 1 comment

Review  

Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle

Melvin R Hayden, Suresh C Tyagi Nutrition & Metabolism 2004, 1:10 (19 October 2004)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Review  

Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: The pleiotropic effects of folate supplementation

Melvin R Hayden, Suresh C Tyagi Nutrition Journal 2004, 3:4 (10 May 2004)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Review  

Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation

Melvin R Hayden, Suresh C Tyagi Cardiovascular Diabetology 2004, 3:1 (4 February 2004)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central | 1 comment

Hypothesis  

Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof

Enrique Z Fisman, Michael Motro, Alexander Tenenbaum Cardiovascular Diabetology 2003, 2:11 (12 September 2003)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Review  

Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR)

Alexander Tenenbaum, Enrique Z Fisman, Michael Motro Cardiovascular Diabetology 2003, 2:4 (23 March 2003)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central